Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in TCRT — Alaunos Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to TCRT Full portfolio

Position in TCRT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$876
+$333 QoQ
Shares Held
388
+104.2% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 29 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TCRT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. TCRT ranks #363 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in TCRT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $876 388
2026-03-31 $543 190
2025-12-31 $574 178
2025-09-30 $440 183
2025-06-30 $886 183
2025-03-31 $316 216
2024-12-31 $528 277
2024-09-30 $1,200 373
2024-06-30 $3,087 4,411
2024-03-31 $12,918 7,138
2023-12-31 $7,679 109,713
2023-09-30 $14,942 114,949
2023-06-30 $74,194 145,482
2023-03-31 $69,589 110,461
2022-12-31 $65,697 101,075
2022-09-30 $151,760 88,234
2022-06-30 $65,506 52,829
2022-03-31 $110,921 170,650
2021-12-31 $345,581 317,048
2021-09-30 $154,485 84,883
2021-06-30 $422,913 160,195
2021-03-31 $690,442 191,790
2020-12-31 $812,479 322,413
2020-09-30 $714,771 283,640
2020-06-30 $839,202 255,855
2020-03-31 $383,121 156,376